200,000+ products from a single source!
sales@angenechem.com
Home > Other Building Blocks > 620-67-7
620-67-7 | Propane-1,2,3-triyl triheptanoate
CAS No: 620-67-7 Catalog No: AG003QS2 MDL No:MFCD00042910
Product Description
Catalog Number:
AG003QS2
Chemical Name:
Propane-1,2,3-triyl triheptanoate
CAS Number:
620-67-7
Molecular Formula:
C24H44O6
Molecular Weight:
428.6026
MDL Number:
MFCD00042910
IUPAC Name:
2,3-di(heptanoyloxy)propyl heptanoate
InChI:
InChI=1S/C24H44O6/c1-4-7-10-13-16-22(25)28-19-21(30-24(27)18-15-12-9-6-3)20-29-23(26)17-14-11-8-5-2/h21H,4-20H2,1-3H3
InChI Key:
PJHKBYALYHRYSK-UHFFFAOYSA-N
SMILES:
CCCCCCC(=O)OC(COC(=O)CCCCCC)COC(=O)CCCCCC
EC Number:
210-647-2
UNII:
2P6O7CFW5K
Properties
Complexity:
421
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
428.314g/mol
Formal Charge:
0
Heavy Atom Count:
30
Hydrogen Bond Acceptor Count:
6
Hydrogen Bond Donor Count:
0
Isotope Atom Count:
0
Molecular Weight:
428.61g/mol
Monoisotopic Mass:
428.314g/mol
Rotatable Bond Count:
23
Topological Polar Surface Area:
78.9A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
7.3
Literature
| Title | Journal |
|---|---|
| GLUT1 deficiency syndrome in clinical practice. | Epilepsy research 20120701 |
| Triheptanoin--a medium chain triglyceride with odd chain fatty acids: a new anaplerotic anticonvulsant treatment? | Epilepsy research 20120701 |
| Triheptanoin in acute mouse seizure models. | Epilepsy research 20120501 |
| Protective and restorative effects of a Commiphora mukul gum resin and triheptanoin preparation on the CCL-110 skin fibroblast cell line. | International journal of cosmetic science 20120401 |
| The ketogenic diet as a treatment paradigm for diverse neurological disorders. | Frontiers in pharmacology 20120101 |
| Anticonvulsant effects of a triheptanoin diet in two mouse chronic seizure models. | Neurobiology of disease 20101201 |
| Current issues regarding treatment of mitochondrial fatty acid oxidation disorders. | Journal of inherited metabolic disease 20101001 |
| Dietary anaplerotic therapy improves peripheral tissue energy metabolism in patients with Huntington's disease. | European journal of human genetics : EJHG 20100901 |
| [Hepatic fatty acid profile of rats with AIN-93 diet-induced steatosis attenuated by the partial substitution of soybean oil by diheptanoin and triheptanoin]. | Arquivos brasileiros de endocrinologia e metabologia 20100801 |
| Validation of an analytical method for the determination of glyceroltriheptanoate (GTH) in processed animal by-products: results of a collaborative study. | Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment 20100601 |
| Effect of dietary fats with odd or even numbers of carbon atoms on metabolic response and muscle damage with exercise in Quarter Horse-type horses with type 1 polysaccharide storage myopathy. | American journal of veterinary research 20100301 |
| Parenteral and enteral metabolism of anaplerotic triheptanoin in normal rats. II. Effects on lipolysis, glucose production, and liver acyl-CoA profile. | American journal of physiology. Endocrinology and metabolism 20100201 |
| Inborn errors of energy metabolism associated with myopathies. | Journal of biomedicine & biotechnology 20100101 |
| Adult Polyglucosan Body Disease (APBD): Anaplerotic diet therapy (Triheptanoin) and demonstration of defective methylation pathways. | Molecular genetics and metabolism 20100101 |
| Effect of triheptanoin on muscle metabolism during submaximal exercise in horses. | American journal of veterinary research 20090801 |
| Use of glyceroltriheptanoate as marker for processed animal by-products: development and validation of an analytical method. | Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment 20090401 |
| [Hepatoprotective effect of diheptanoin and tritreptanoin chronic consumption against steatosis in rats]. | Arquivos brasileiros de endocrinologia e metabologia 20081001 |
| Carnitine palmitoyltransferase II deficiency: successful anaplerotic diet therapy. | Neurology 20080722 |
| Effects of short-term and long-term treatment with medium- and long-chain triglycerides ketogenic diet on cortical spreading depression in young rats. | Neuroscience letters 20080321 |
| Parenteral and enteral metabolism of anaplerotic triheptanoin in normal rats. | American journal of physiology. Endocrinology and metabolism 20061001 |
| Anaplerotic diet therapy in inherited metabolic disease: therapeutic potential. | Journal of inherited metabolic disease 20060101 |
| Pyruvate carboxylase deficiency: clinical and biochemical response to anaplerotic diet therapy. | Molecular genetics and metabolism 20050401 |
| Treatment of cardiomyopathy and rhabdomyolysis in long-chain fat oxidation disorders using an anaplerotic odd-chain triglyceride. | The Journal of clinical investigation 20020715 |
| Final report on the safety assessment of trilaurin, triarachidin, tribehenin, tricaprin, tricaprylin, trierucin, triheptanoin, triheptylundecanoin, triisononanoin, triisopalmitin, triisostearin, trilinolein, trimyristin, trioctanoin, triolein, tripalmitin, tripalmitolein, triricinolein, tristearin, triundecanoin, glyceryl triacetyl hydroxystearate, glyceryl triacetyl ricinoleate, and glyceryl stearate diacetate. | International journal of toxicology 20010101 |
Related Products
Featured Products
© 2019 Angene International Limited. All rights Reserved.